Literature DB >> 640733

Lymphocyte blastogenic responses to influenza virus antigens after influenza infection and vaccination in humans.

R Dolin, B R Murphy, E A Caplan.   

Abstract

Virus-specific in vitro cell-mediated immune responses were investigated in 20 normal volunteers who were challenged with liver influenza A/VIC/3/75 (H3N2) virus and in 13 volunteers who were vaccinated with inactivated vaccine containing A/VIC and A/NJ/8/76 (HswN1) antigens. Lymphocyte cultures were established from peripheral blood samples obtained prior to and at various times after infection or vaccination. Blastogenesis was determined by [3H]thymidine incorporation after stimulation of cultures with purified, inactivated, whole influenza viruses. Six days after infection, significantly elevated levels of blastogenesis were observed after in vitro stimulation with A viruses of hemagglutinin and neuraminidase subtypes that were the same as (H3N2) or antigenically distinct from (Heq1Neq1 or HswN1) those of the challenge virus, although maximum stimulation was noted with virus of the same hemagglutinin subtype (H3) as the challenge virus. Similar although more prolonged blastogenic responses were noted in lymphocyte cultures from vaccinees who had serum antibody rises after vaccination. The kinetics of these responses suggest that cell-mediated immunity may play a role in early events after infection and vaccination with influenza virus.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 640733      PMCID: PMC422269          DOI: 10.1128/iai.19.3.867-874.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Preparation and immunogenicity of an influenza virus hemagglutinin and neuraminidase subunit vaccine.

Authors:  W G Laver; R G Webster
Journal:  Virology       Date:  1976-02       Impact factor: 3.616

2.  Cell-mediated immune responses in humans after induced infection with influenza A virus.

Authors:  R Dolin; D D Richman; B R Murphy; A S Fauci
Journal:  J Infect Dis       Date:  1977-05       Impact factor: 5.226

3.  Effect of viral and bacterial pneumonias on cell-mediated immunity in humans.

Authors:  C A Kauffman; C C Linnemann; G M Schiff; J P Phair
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

4.  Influenza: response of T-cell lymphopenia to thymosin.

Authors:  M Scheinberg; N R Blacklow; A L Goldstein; T A Parrino; F B Rose; E S Cathcart
Journal:  N Engl J Med       Date:  1976-05-27       Impact factor: 91.245

5.  Lymphocyte populations in acute viral gastroenteritis.

Authors:  R Dolin; R C Reichman; A S Fauci
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

6.  Alternate-day prednisone therapy and human lymphocyte subpopulations.

Authors:  A S Fauci; D C Dale
Journal:  J Clin Invest       Date:  1975-01       Impact factor: 14.808

7.  Lymphocyte reactivity to influenza virus in man.

Authors:  P J Cole; M E Molyneux
Journal:  Immunology       Date:  1975-10       Impact factor: 7.397

8.  Chromatographic isolation of the hemagglutinin polypeptides from influenza virus vaccine and determination of their amino-terminal sequences.

Authors:  D J Bucher; S S Li; J M Kehoe; E D Kilbourne
Journal:  Proc Natl Acad Sci U S A       Date:  1976-01       Impact factor: 11.205

9.  Studies on the primary structure of the influenza virus hemagglutinin.

Authors:  J J Skehel; M D Waterfield
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

10.  The analysis of the monoclonal immune response to influenza virus. II. The antigenicity of the viral hemagglutinin.

Authors:  W Gerhard
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

View more
  8 in total

Review 1.  Is there a role for a mucosal influenza vaccine in the elderly?

Authors:  E M Corrigan; R L Clancy
Journal:  Drugs Aging       Date:  1999-09       Impact factor: 3.923

2.  Non-specific effects of avian retrovirus co-incubation on lymphocyte function: abrogation of antigen- and mitogen-induced proliferative responsiveness.

Authors:  E Israel; M Yu; M A Wainberg
Journal:  Immunology       Date:  1979-09       Impact factor: 7.397

3.  Influence of prior cellular immunity on the in vitro lymphocyte response to virus antigens after influenza vaccination.

Authors:  W A Briggs
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

4.  Serum neutralizing antibody and lymphocyte transformation responses after influenza B virus infections.

Authors:  J M Zahradnik; A L Frank; L H Taber
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

5.  Cytotoxic lymphocytes and antibody-dependent complement-mediated cytotoxicity induced by administration of influenza vaccine.

Authors:  G V Quinnan; F A Ennis; C U Tuazon; M A Wells; G M Butchko; R Armstrong; C McLaren; J F Manischewitz; S Kiley
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

6.  Cell-mediated immune response of human lymphocytes to influenza A/USSR (H1N1) virus infection.

Authors:  A Lazar; P F Wright
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

7.  Humoral and cellular immune responses of seronegative children vaccinated with a cold-adapted influenza A/HK/123/77 (H1N1) recombinant virus.

Authors:  A Lazar; N Okabe; P F Wright
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

8.  In vitro antigen-induced antibody responses to hepatitis B surface antigen in man. Kinetic and cellular requirements.

Authors:  T R Cupps; J L Gerin; R H Purcell; P K Goldsmith; A S Fauci
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.